Alison Binns

Dr. Alison Binns

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2016 in BMJ Open
Verified
Journal Article
Open access
PDF file
DTDeanna J Taylor
Deanna J Taylor
AHAngharad E Hobby
Angharad E Hobby
ABAlison Binns
Alison Binns
DCDavid P Crabb
David P Crabb
Objectives To review systematically the evidence of age-related macular degeneration (AMD) affecting real-world visual ability and quality of life (QoL). To explore trends in specific topics within this body of the literature. Design Systematic review. Methods A systematic literature search was carried out using MEDLINE, EMBASE, CINAHL, PsycINFO, PsychARTICLES and Health and Psychosocial Instruments for articles published up to January 2015 for studies including people diagnosed with AMD, assessing real-world visual ability or QoL as an outcome. Two researchers screened studies for eligibility. Details of eligible studies including study design, characteristics of study population and outcomes measured were recorded in a data extraction table. All included studies underwent quality appraisal using the Mixed Methods Appraisal Tool 2011 Version (MMAT). Results From 5284 studies, 123 were eligible for inclusion. A range of approaches were identified, including performance-based methods, quantitative and qualitative patient-reported outcome measures (PROMs). AMD negatively affects tasks including mobility, face recognition, perception of scenes, computer use, meal preparation, shopping, cleaning, watching TV, reading, driving and, in some cases, self-care. There is evidence for higher rates of depression among people with AMD than among community dwelling elderly. A number of adaptation strategies have been associated with AMD of varying duration. Much of the research fails to report the type of AMD studied (59% of included studies) or the duration of disease in participants (74%). Of those that do report type studied, the breakdown is as follows: wet AMD 20%, dry AMD 4% and both types 17%. Conclusions There are many publications highlighting the negative effects of AMD in various domains of life. Future research should focus on delivering some of this research knowledge into patient management and clinical trials and differentiating between the types of AMD.

1 January 2012 in Survey of Ophthalmology
Verified
Journal Article
Closed access
ABAlison Binns
Alison Binns
CBCatey Bunce
Catey Bunce
CDChris Dickinson
Chris Dickinson
RHRobert Harper
Robert Harper
RTRhiannon Tudor-Edwards
Rhiannon Tudor-Edwards
TMTom H. Margrain
Tom H. Margrain

1 December 2011 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
AWAshley Wood
Ashley Wood
ABAlison Binns
Alison Binns
TMTom Margrain
Tom Margrain
WDWolfgang Drexler
Wolfgang Drexler
BPBoris Považay
Boris Považay
NSNik Sheen
Nik Sheen

6 July 2010 in Documenta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
KMKatharine E. Mortlock
Katharine E. Mortlock
ABAlison Binns
Alison Binns
YAYousef H. Aldebasi
Yousef H. Aldebasi
RNRachel V. North
Rachel V. North

23 November 2017 in Ophthalmic and Physiological Optics
Verified
Journal Article
Open access
PDF file
DTDeanna J. Taylor
Deanna J. Taylor
LELaura A. Edwards
Laura A. Edwards
ABAlison Binns
Alison Binns
DCDavid P. Crabb
David P. Crabb
Purpose: A realistic description of visual symptoms associated with dry age‐related macular degeneration ( AMD ) is important for raising awareness of the condition and educating patients. This study aimed to develop a set of descriptors for dry AMD and examine the realism of images currently and frequently used to show visual symptoms of the condition. Methods: Volunteers with dry AMD with a range of disease severity were given an eye examination and were asked to describe visual symptoms of their condition in a conversational interview. Participants were also asked to comment on a photograph typically used to portray the visual symptoms of AMD . Interviews were audio recorded, transcribed and subjected to content analysis. Results: Twenty‐nine participants were interviewed. Median (interquartile range [ IQR ]) age was 75 (70, 79) years. Median ( IQR ) binocular visual acuity ( VA ) and Pelli‐Robson contrast sensitivity ( CS ) was 0.2 (0.18, 0.36) log MAR and 1.65 (1.50, 1.95) log CS respectively. Three, 17 and nine patients had early, intermediate and late (geographic atrophy, GA ) AMD , respectively. The most frequently reported descriptor group was blur ( n = 13) followed by missing ( n = 10) and distortion ( n = 7). We chose the most popular image used to portray the visual symptoms of dry AMD based on an internet search and showed this to 21 participants. Sixteen participants (76% [95% confidence interval 53–92%]), including three out of the seven people with geographic atrophy, unequivocally rejected the realism of the image. Conclusions: People with dry AMD use a wide range of descriptors for their visual experience. Visual symptoms of dry AMD as portrayed by commonly shown images were not the experience of most people in this study.

15 April 2014 in Ophthalmic and Physiological Optics
Verified
Journal Article
Closed access
PDF file
AGAllannah J. Gaffney
Allannah J. Gaffney
TMTom H. Margrain
Tom H. Margrain
CBCatey Bunce
Catey Bunce
ABAlison Binns
Alison Binns